Download Sample
Add to CartMastitis Market
By Type;
Infectious Mastitis, Non-Infectious Mastitis and OthersBy Diagnosis;
Physical Examination, Milk Sample Examination and OthersBy Treatment;
Medication, Physical Therapy and OthersBy End User;
Hospitals, Specialty Clinics, Home Healthcare and OthersBy Medication;
Antibiotics, NSAIDs and OthersBy Distribution Channel;
Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Mastitis Market Overview
Mastitis Market (USD Million)
Mastitis Market was valued at USD 23,217.74 million in the year 2024. The size of this market is expected to increase to USD 62,136.57 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 15.1%.
Mastitis Market
*Market size in USD million
CAGR 15.1 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 15.1 % |
| Market Size (2024) | USD 23,217.74 Million |
| Market Size (2031) | USD 62,136.57 Million |
| Market Concentration | Low |
| Report Pages | 372 |
Major Players
- Pfizer Inc.
- Boehringer Ingelheim International GmbH
- Zoetis Inc.
- Merck & Co., Inc.
- Bayer AG
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Mastitis Market
Fragmented - Highly competitive market without dominant players
The Mastitis Market has experienced steady growth, primarily driven by the increasing demand for high-quality dairy products and the need for improved animal health. Mastitis, an inflammation of the mammary glands in dairy animals, remains a major concern for the dairy industry due to its negative impact on milk yield, quality, and animal welfare. As the dairy sector expands, addressing mastitis effectively is crucial to maintain optimal milk production and avoid economic losses.
Prevalence and Economic Impact of Mastitis
Mastitis is one of the most common and costly diseases affecting dairy herds worldwide, with an estimated 30% of dairy herds experiencing some form of the disease. This condition not only reduces milk production but also lowers milk quality, leading to significant financial losses for farmers. In addition, mastitis is linked to increased veterinary care costs and the culling of infected animals, further compounding its economic impact.
Innovation in Treatment and Prevention Strategies
Advances in veterinary treatments have revolutionized the way mastitis is managed. Traditional therapies, such as antibiotics and anti-inflammatory medications, remain crucial in combating mastitis, but newer treatments are focusing on minimizing antibiotic resistance. More than 40% of the mastitis treatment market is comprised of antibiotics, though alternative solutions, including vaccines and probiotics, are gaining ground as effective, sustainable options.
Surge in Dairy Consumption and Market Growth
With the global rise in dairy consumption, driven by growing populations and evolving dietary habits, the need for healthier and more productive dairy herds is more pronounced than ever. As demand for dairy products like milk, cheese, and yogurt increases, farmers are prioritizing the health of their livestock, including the management of mastitis. As a result, 50% of dairy producers have incorporated advanced mastitis management practices to ensure higher-quality milk production and meet consumer demands.
Technological Advancements in Mastitis Detection
Technological innovation is transforming how mastitis is diagnosed and managed on dairy farms. Automated monitoring systems, including sensors and real-time milk composition analysis, are increasingly being used to detect early signs of mastitis before visible symptoms appear. Currently, 35% of dairy farms globally use automated systems for mastitis detection, enhancing early intervention and reducing reliance on traditional, labor-intensive methods.
Mastitis Market Key Takeaways
-
Rising incidence of bovine mastitis is increasing the demand for effective veterinary treatments and management solutions.
-
Dairy industry expansion and the need for milk quality improvement are key factors driving market growth.
-
Antibiotic therapies and intramammary infusions remain the most common approaches for treating infections.
-
Technological advancements in rapid diagnostics are improving detection and early prevention of mastitis.
-
Asia-Pacific region shows rising adoption of mastitis control programs due to increased dairy production.
-
Manufacturers are investing in developing antimicrobial alternatives to reduce antibiotic dependency.
-
Growing focus on animal welfare and sustainable dairy practices supports the expansion of the mastitis market.
Bisphosphonates Market Key Takeaways
-
Rising cases of osteoporosis and bone disorders are increasing the demand for bisphosphonate-based drugs.
-
Aging population and growing awareness of bone health are major factors driving market expansion.
-
Oral and intravenous formulations are widely used to enhance bone density and strength in patients.
-
Pharmaceutical companies are focusing on developing safer drugs with improved efficacy and fewer side effects.
-
Asia-Pacific region is witnessing strong growth due to an increase in osteoporosis diagnosis and healthcare access.
-
Collaborations and research initiatives are supporting innovation in long-acting bisphosphonate formulations.
-
Growing emphasis on preventive treatment and postmenopausal bone care is boosting market demand.
Mastitis Market Recent Developments
- In October 2022, NovaQuest Capital Management invested over USD 20 million in Mileutis Ltd., a biopharmaceutical innovator focused on reducing antibiotic use in livestock. The funding supports Mileutis’s final-stage development of a novel therapy for bovine mastitis, aimed at improving animal health and enhancing dairy farm productivity through sustainable solutions.
- In August 2022, PortaCheck launched the PortaReader, an innovative handheld device that enables on-site detection of subclinical mastitis in cows. By analyzing fresh milk samples directly on the farm, the device allows for rapid and accurate diagnosis, helping farmers improve herd health management and maintain milk quality through proactive disease control.
Mastitis Market Segment Analysis
In this report, the Mastitis Market has been segmented by Type, Diagnosis, Treatment, End User, Medication, Distribution Channel and Geography. The market is evolving due to the increasing prevalence of bovine and human mastitis cases, advancements in diagnostic technologies, and growing awareness of early detection and therapeutic management. Research initiatives focused on antimicrobial resistance and non-antibiotic therapies are also reshaping clinical approaches.
Mastitis Market, Segmentation by Type
The Type segment classifies mastitis based on etiology and pathophysiology, influencing treatment protocols and prevention strategies. With growing emphasis on rapid pathogen detection and herd health management, this segmentation remains crucial for product and therapy development.
Infectious Mastitis
Infectious Mastitis is the most prevalent form, caused by bacterial pathogens such as Staphylococcus aureus and Escherichia coli. Efforts to improve antibiotic stewardship and vaccine development have driven technological innovation and adoption of rapid molecular diagnostics.
Non-Infectious Mastitis
Non-Infectious Mastitis results from physical injury, chemical irritation, or allergic reactions. This segment is witnessing increased clinical attention as researchers explore anti-inflammatory therapies and regenerative medicine to manage chronic inflammation without antibiotics.
Others
The Others category includes autoimmune and idiopathic cases that remain challenging to diagnose. Continuous R&D into genetic susceptibility and immunomodulatory approaches supports potential breakthroughs in long-term management.
Mastitis Market, Segmentation by Diagnosis
The Diagnosis segment emphasizes the tools and methods used to identify mastitis, ranging from clinical evaluation to molecular assays. Rising demand for point-of-care testing and digital monitoring systems is transforming veterinary and human healthcare diagnostics.
Physical Examination
Physical Examination remains the first-line diagnostic approach, enabling clinicians to detect localized swelling, redness, and pain. Despite its simplicity, it is increasingly complemented by smart imaging devices and mobile diagnostic applications.
Milk Sample Examination
Milk Sample Examination is central to pathogen identification and antibiotic sensitivity testing. The integration of automated milk analyzers and PCR-based assays has enhanced detection accuracy by over 90%, streamlining treatment decisions.
Others
The Others category includes serological and imaging-based diagnostics used for complex or recurrent cases. Growing interest in biosensor technology and machine learning tools is expected to improve diagnostic precision further.
Mastitis Market, Segmentation by Treatment
The Treatment segment covers therapeutic approaches designed to alleviate inflammation, combat infection, and restore tissue integrity. Innovations in drug delivery systems and personalized therapy continue to enhance treatment outcomes.
Medication
Medication remains the most widely used intervention, including antibiotics and anti-inflammatory drugs. Recent research promotes targeted antimicrobial therapies to reduce drug resistance and maintain milk quality.
Physical Therapy
Physical Therapy methods such as ultrasound therapy and heat treatment are increasingly applied for pain relief and improved circulation. The integration of wearable therapeutic devices has strengthened this segment’s clinical relevance.
Others
The Others category encompasses probiotic, phytotherapeutic, and immunotherapy-based solutions. These alternatives are gaining traction due to their eco-friendly and residue-free properties, aligning with sustainable livestock management trends.
Mastitis Market, Segmentation by End User
The End User segment highlights key institutions and healthcare providers managing mastitis cases. Increasing collaboration among veterinary centers, research institutions, and healthcare providers is fueling innovation in treatment delivery and patient management.
Hospitals
Hospitals account for a major share owing to advanced diagnostic infrastructure and access to specialized care. The availability of multidisciplinary teams and inpatient management supports effective mastitis treatment protocols.
Specialty Clinics
Specialty Clinics focus on targeted care for chronic and recurrent mastitis cases. They are expanding through partnerships with biopharmaceutical firms to test novel therapies and clinical devices.
Home Healthcare
Home Healthcare adoption is growing with the rise of portable diagnostic tools and telemedicine platforms. Patients benefit from self-monitoring systems and real-time consultation for ongoing treatment adherence.
Others
Others include research facilities and veterinary centers contributing to clinical trials and experimental studies. Their role in advancing antimicrobial resistance studies remains pivotal to the global research framework.
Mastitis Market, Segmentation by Medication
The Medication segment focuses on pharmaceutical classes employed in mastitis treatment. Strategic collaborations among pharma companies and biotech startups are enhancing drug formulations to improve efficacy and reduce side effects.
Antibiotics
Antibiotics form the cornerstone of mastitis treatment, targeting bacterial pathogens effectively. However, growing concerns over antimicrobial resistance have spurred the development of alternative antibacterial compounds and controlled dosage systems.
NSAIDs
NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) help reduce pain, swelling, and fever associated with mastitis. Their integration with antibiotic regimens has demonstrated improved patient recovery rates and compliance.
Others
Others include hormonal therapies, probiotics, and herbal medicines. These are gaining momentum as complementary approaches, emphasizing holistic and side-effect-free recovery.
Mastitis Market, Segmentation by Distribution Channel
The Distribution Channel segment examines how mastitis medications and equipment reach end users. The increasing presence of digital pharmacies and bulk procurement systems is redefining the accessibility of treatment solutions.
Direct Tender
Direct Tender channels dominate institutional purchases, particularly in hospital and government healthcare sectors. This system ensures consistent drug supply, quality assurance, and competitive pricing structures.
Hospital Pharmacy
Hospital Pharmacy distribution supports prescription-based dispensing and inventory control. It plays a critical role in ensuring timely patient access to required therapeutic agents.
Retail Pharmacy
Retail Pharmacy continues to expand through chain pharmacies and local distributors. These outlets facilitate widespread product reach, including both over-the-counter and prescription-based treatments.
Online Pharmacy
Online Pharmacy is rapidly gaining momentum, driven by digital healthcare platforms and e-prescription systems. The convenience of home delivery and transparent pricing enhances user preference, especially in urban regions.
Others
Others include wholesale distributors and regional suppliers that cater to rural and underserved areas. Their logistical networks support continuity of supply in developing markets.
Mastitis Market, Segmentation by Geography
In this report, the Mastitis Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
North America
North America dominates the market due to well-established veterinary care infrastructure and high awareness of mastitis prevention and treatment. Government-backed animal health programs and investment in biopharmaceutical research continue to drive innovation.
Europe
Europe maintains significant market share through its focus on antibiotic-free therapies and strong regulatory frameworks. Expanding adoption of digital herd management tools is further supporting market growth.
Asia Pacific
Asia Pacific shows strong expansion driven by increasing dairy production, veterinary service penetration, and regional government initiatives promoting livestock health. Rapid urbanization and rising disposable incomes also contribute to market expansion.
Middle East and Africa
Middle East and Africa regions are witnessing steady growth through government awareness campaigns and import-based drug availability. Strengthening partnerships with international veterinary companies are expected to enhance access to advanced therapies.
Latin America
Latin America is experiencing growing demand for mastitis diagnostics and treatment tools, particularly in Brazil and Argentina. Expanding dairy farming operations and public-private initiatives are supporting the region’s upward trajectory.
Mastitis Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Mastitis Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints, and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Demand for Dairy Products
- Growing Prevalence of Mastitis
- Rising Emphasis on Animal Welfare
- Technological Advancements in Mastitis Management
-
Regulatory Support for Sustainable Agriculture - Regulatory initiatives promoting sustainable agriculture are playing a crucial role in driving the growth of the mastitis market. As governments and international organizations emphasize animal welfare, responsible antibiotic use, and environmentally sound dairy practices, dairy producers are increasingly encouraged to adopt effective mastitis prevention and management strategies. These regulations align with broader goals of improving milk quality, herd productivity, and public health outcomes by minimizing the misuse of antibiotics and supporting disease control through early detection and targeted treatments.
Supportive policies such as government subsidies, animal health certifications, and sustainability compliance standards are accelerating the adoption of advanced tools for mastitis diagnosis and control. These include intrafarm testing kits, selective therapy protocols, and digital herd monitoring systems that enhance early intervention and reduce long-term costs. As sustainable agriculture becomes a core component of livestock policy worldwide, regulatory support is expected to significantly boost demand for effective mastitis solutions, further strengthening the global market.
Restraints
- Antibiotic Resistance and Concerns About Antimicrobial Use
- High Cost of Mastitis Management Products
- Limited Access to Veterinary Care in Developing Regions
- Challenges in Early Detection and Diagnosis of Mastitis
-
Regulatory Hurdles and Compliance Requirements - Regulatory hurdles and demanding compliance standards present a major limitation to the growth of the mastitis market. Bringing new veterinary products to market requires navigating rigorous approval processes, which include lengthy safety assessments, efficacy trials, and compliance with complex guidelines set by regulatory bodies. These steps not only increase development costs but also extend time-to-market, posing significant challenges for smaller firms with limited resources. The strict oversight is particularly evident in products related to antibiotic usage, where growing concerns about resistance have led to tighter controls and evolving requirements.
The lack of regulatory uniformity across regions complicates international market entry. Manufacturers must adapt to varying national laws regarding antimicrobial residue limits, treatment protocols, and animal welfare standards, all of which require customized documentation and approval strategies. These inconsistencies reduce operational efficiency and raise the cost of global compliance. As a result, such regulatory complexities can limit innovation, hinder product accessibility, and slow the adoption of advanced mastitis solutions in both developed and emerging markets.
Opportunities
- Development of Novel Vaccines and Therapeutics
- Expansion of Mastitis Control Programs
- Adoption of Precision Livestock Farming Technologies
- Growing Investment in Research and Development
-
Strategic Partnerships and Collaborations in the Dairy Industry - The growing trend of strategic partnerships and collaborations within the dairy industry is creating promising opportunities for the mastitis market. Veterinary pharmaceutical companies, dairy cooperatives, technology providers, and research institutions are increasingly working together to develop and implement advanced solutions for mastitis prevention, diagnosis, and treatment. These partnerships allow for the integration of veterinary expertise with real-world farming practices, leading to more practical and scalable disease management approaches that improve herd health and productivity.
Collaborative efforts are also accelerating innovation in diagnostic technologies, such as on-farm testing kits, automated milking systems with in-line sensors, and real-time health monitoring platforms. By combining technical expertise and data analytics, these partnerships help deliver early detection tools that support targeted interventions, reducing reliance on blanket antibiotic use and aligning with antimicrobial stewardship initiatives. Such advancements enhance the efficiency of mastitis control while promoting sustainable dairy farming practices.
Strategic alliances also extend to educational programs and field training, empowering farmers with knowledge on hygiene protocols, herd management, and treatment compliance. These initiatives improve on-farm decision-making and increase adoption of best practices, which contribute to long-term market growth. By aligning the goals of commercial stakeholders and the agricultural community, these partnerships help ensure that mastitis management solutions are both economically viable and clinically effective.
As the dairy industry continues to modernize, these collaborative models are expected to play a pivotal role in driving innovation, expanding market reach, and improving animal health outcomes. Companies that actively engage in cross-sector partnerships are better positioned to develop integrated, farmer-friendly solutions that meet the evolving needs of the mastitis market while supporting broader goals of quality milk production and sustainability.
Mastitis Market Competitive Landscape Analysis
Mastitis Market is witnessing strong growth driven by increasing prevalence of dairy infections and strategic partnerships among veterinary and pharmaceutical companies. Over 50% of players are engaging in mergers and collaborations to enhance product portfolios, fostering technological advancements and enabling sustainable market expansion across livestock and dairy management sectors.
Market Structure and Concentration
The market demonstrates moderate concentration, with top companies controlling over 60% of total share. Strategic alliances and mergers shape competitive positioning, while emerging players focus on innovation-driven growth. Consolidation and targeted expansion strategies are redefining market structure and ensuring long-term competitiveness.
Brand and Channel Strategies
Leading manufacturers leverage multi-channel distribution and brand differentiation strategies to maximize market reach. Approximately 55% of players adopt partnerships to strengthen sales and penetration. Focus on technological innovation and strategic collaborations enhances brand equity, driving sustained growth and long-term market expansion.
Innovation Drivers and Technological Advancements
Technological advancements in veterinary drugs, diagnostic tools, and automated treatment systems are central to market growth. Around 45% of players invest heavily in R&D to implement innovative strategies. Collaborative efforts and partnerships foster improved treatment efficacy, promoting continuous innovation and market expansion.
Regional Momentum and Expansion
North America and Europe hold a combined share exceeding 65% due to advanced dairy practices and strategic partnerships. Emerging regions are witnessing significant growth through expansion and cross-border collaborations. Regional initiatives focused on technological innovation and farm management drive balanced expansion and stronger market presence.
Future Outlook
The market’s future outlook indicates sustained growth fueled by technological innovation and strategic collaborations. Mergers and partnerships are projected to influence over 50% of competitive strategies. Continued investment in advanced treatments and targeted expansion initiatives will strengthen market positioning and long-term resilience.
Key players in Mastitis Market include:
- Zoetis
- Merck & Co. (MSD Animal Health)
- Boehringer Ingelheim
- Elanco Animal Health
- Bayer AG
- Ceva Santé Animale
- Virbac
- DeLaval
- ImmuCell Corporation
- HIPRA
- Norbrook Laboratories
- Vetoquinol
- Phibro Animal Health Corporation
- Zoovet
- Neogen Corporation
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Diagnosis
- Market Snapshot, By Treatment
- Market Snapshot, By End User
- Market Snapshot, By Medication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Mastitis Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Demand for Dairy Products
- Growing Prevalence of Mastitis
- Rising Emphasis on Animal Welfare
- Technological Advancements in Mastitis Management
- Regulatory Support for Sustainable Agriculture
- Restraints
- Antibiotic Resistance and Concerns About Antimicrobial Use
- High Cost of Mastitis Management Products
- Limited Access to Veterinary Care in Developing Regions
- Challenges in Early Detection and Diagnosis of Mastitis
- Regulatory Hurdles and Compliance Requirements
- Opportunities
- Development of Novel Vaccines and Therapeutics
- Expansion of Mastitis Control Programs
- Adoption of Precision Livestock Farming Technologies
- Growing Investment in Research and Development
- Strategic Partnerships and Collaborations in the Dairy Industry
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Mastitis Market, By Type, 2021 - 2031 (USD Million)
- Infectious Mastitis
- Non-Infectious Mastitis
- Others
- Mastitis Market, By Diagnosis, 2021 - 2031 (USD Million)
- Physical Examination
- Milk Sample Examination
- Others
- Mastitis Market, By Treatment, 2021 - 2031 (USD Million)
- Medication
- Physical Therapy
- Others
- Mastitis Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Specialty Clinics
- Home Healthcare
- Others
- Mastitis Market, By Medication, 2021 - 2031 (USD Million)
- Antibiotics
- NSAIDs
- Others
- Mastitis Market, By Distribution Channel, 2021 - 2031 (USD Million)
- Direct Tender
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- Mastitis Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN(Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Mastitis Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Zoetis
- Merck & Co. (MSD Animal Health)
- Boehringer Ingelheim
- Elanco Animal Health
- Bayer AG
- Ceva Santé Animale
- Virbac
- DeLaval
- ImmuCell Corporation
- HIPRA
- Norbrook Laboratories
- Vetoquinol
- Phibro Animal Health Corporation
- Zoovet
- Neogen Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market